A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration
for Neovascular Age-related Macular Degeneration
18 locations incl. Phoenix
Sponsor: Sanofi
Sex: All·Age: 50 - 90
Code: NCT06660667·Phase 1, Phase 2·Recruiting